<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-G0BERNYB</identifier><date>2004</date><creator>Sedmak, Boris</creator><relation>documents/doc/G/URN_NBN_SI_doc-G0BERNYB_001.pdf</relation><relation>documents/doc/G/URN_NBN_SI_doc-G0BERNYB_001.txt</relation><format format_type="issue">2</format><format format_type="volume">8</format><format format_type="type">article</format><format format_type="extent">str. 76</format><identifier identifier_type="ISSN">1408-1741</identifier><identifier identifier_type="COBISSID_HOST">19004377</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-G0BERNYB</identifier><language>slv</language><publisher>Onkološki inštitut Ljubljana</publisher><source>Onkologija (Ljubljana)</source><rights>BY</rights><subject language_type_id="slv">Fosfodiesterazni inhibitorji</subject><subject language_type_id="eng">Penile Erection</subject><subject language_type_id="slv">Penis, erekcija</subject><subject language_type_id="eng">Phosphodiesterase Inhibitors</subject><subject language_type_id="slv">Prostata, novotvorbe</subject><subject language_type_id="eng">Prostatectomy</subject><subject language_type_id="slv">Prostatektomija</subject><subject language_type_id="eng">Prostatic Neoplasms</subject><title>"Ali bolnik z rakom prostate lahko uporablja viagro?"</title></Record>